Morgan Wallen Blocked From A New No. 1 By Two Of Pop’s Biggest Hitmakers
Morgan Wallen's new single "I’m the Problem" from his forthcoming album of the same name denied a Hot 100 No. 1 start by Lady ...
Truist maintains Buy on Protagonist Therapeutics with $60 target
Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...